LYMIT-DIS Second Meeting: September 2018

Pamplona, Spain: 2nd Meeting of the LYMIT-DIS consortium

The team members met on 19th-21st of September 2018 at the CIMA institute in Pamplona, Spain hosted by Partner 5 leader Dr Arantxa Gonzalez-Miqueo.

The Meeting was dedicated to intense & dynamic exchanges on the advancement of Project tasks and deliverables, with special focus on stimulating exchanges of methods and materials between our different teams to further advance the work packages.

Participants:

  • Partner 1: Ebba Brakenhielm & Paul Mulder
  • Partner 2: Marc van Bilsen & Annika Kuhn
  • Partner 3: Anna Ratajska
  • Partner 4: Liz Jones & Steven Simmonds & Ilona Cuijpers
  • Partner 5: Arantxa Gonzales Miqueo & Javier Díez & Begoña López & Ujué Moreno & Susana Ravassa

 LYMIT DISPamplonaheart

Postdoctoral position in France

Searching an immunology-trained research fellow for a postdoc on immune-lymphatic crosstalk

The aim of our LYMIT-DIS European ERA-CVD project project is to identify and evaluate innovative treatments to limit the cardiac impact of metabolic syndrome and to prevent the transition from cardiac dysfunction to Heart Failure.

The postdoctoral research project will address the links between cardiac inflammation and lymphatics through investigation of the cross-talk that occurs between cardiac lymphatic endothelial cells (LEC) and immune cells in expeimental models of cardiac inflammation. The specific aspects that will be developed include a) assessment of chemokine ligand and receptor expression in cardiac LECs and immune cells infiltrating the heart; b) impact on lymphatic endothelium of immune cell-derived modulators (cytokines, lipids).

 Required skills (what you need to know):

  • Flow cytometric cell analysis and sorting, expression analyses (sequencing and single cell approaches a plus), immune cell culture, confocal microscopy
  • General knowledge in immunology, special knowledge in chemokine signaling a clear plus

 Offered skills (what we may teach you):

  • Vascular biology including angiogenesis and lymphangiogenesis assays, cardiac physiology, histology & immunohistochemistry, whole mount staining & tissue clarification for 3D imaging, endothelial cell culture, epigenetics, drug delivery
  • General knowledge in cardiovascular pathophysiology including gender aspects, skills in European project management & dissemination

Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. Deadline 20th of August 2018

The host laboratory, Inserm U1096, directed by Pr Vincent Richard https://insermu1096.fr/ is focused on evaluations of endothelial and cardiac dysfunctions with the aim to develop novel treatment strategies for cardiovascular diseases, especially Heart Failure.

Publication list


Members of the team

This email address is being protected from spambots. You need JavaScript enabled to view it., CR1 Inserm
This email address is being protected from spambots. You need JavaScript enabled to view it., MD, PhD student

This email address is being protected from spambots. You need JavaScript enabled to view it., Technician

This email address is being protected from spambots. You need JavaScript enabled to view it., Lecturer (MCF)

Mahmoud Houssari, PhD student
Manon Lefrancois, Master 2 student

This email address is being protected from spambots. You need JavaScript enabled to view it. Renet, Technician

This email address is being protected from spambots. You need JavaScript enabled to view it., PhD student

   

March 6th LYMIT-DIS project official start date as one out of 14 European Project selected by ERA-CVD in 2016

ERA-NET on Cardio Vascular Diseases (ERA-CVD)

Cardiovascular diseases (CVD) are the major cause of death in Europe. CVD research is a crucial area in health research, hence an effective coordination of research at national and EU level, increased cross-disciplinary interaction and research advancements are needed. By gathering their forces and funding capacities so far 18 countries joined to set up a new ERA-Net Cofund action (European Research Area Network co-funded by the European Commission, EC) dedicated to cardiovascular diseases (ERA-CVD) .

Read more: March 6th LYMIT-DIS project official start date as one out of 14 European Project selected by...

LYMIT-DIS

Targeted Lymphatic and Microvessel Treatments in metabolic-DISease HFpEF

Réalisation Internet Bordeaux.

Contact Us

Legal mentions